Improved therapeutic sclerosing microfoams and methods and devices for making them are provided that have advantage in producing a consistent profile injectable foam with minimal input by the physician yet using high volume percentages of blood dispersible gases, thus avoiding use of potentially hazardous amounts of nitrogen.

 
Web www.patentalert.com

< Dimethyl fumarate for the treatment of multiple sclerosis

> Modulation of expression of STAT-1 dependent genes

~ 00426